Basic fibroblast growth factor (bFGF), also known as FGF-2, is a critical protein involved in the regulation of cell growth, differentiation, and tissue repair. The GMP (Good Manufacturing Practice) recombinant human bFGF protein is widely used in research, particularly in cell culture systems, regenerative medicine, and therapeutic applications. Its production under GMP standards ensures the highest level of purity, safety, and consistency, making it suitable for clinical and pharmaceutical use.
What is bFGF?
bFGF is a member of the fibroblast growth factor family, which plays key roles in angiogenesis (the formation of new blood vessels), wound healing, and embryonic development. In cell biology, bFGF is commonly used as a supplement in stem cell culture systems, where it helps maintain pluripotency and promotes the proliferation of various cell types, such as mesenchymal stem cells (MSCs) and induced pluripotent stem cells (iPSCs).
For more information on the biological function of bFGF, check out resources from the National Institutes of Health (NIH) and PubMed.
Applications of GMP Recombinant Human bFGF Protein
- Cell Culture and Regenerative Medicine:
GMP-grade bFGF is extensively used in stem cell research and regenerative medicine. It supports the growth and maintenance of stem cells, making it vital for creating cell-based therapies. Researchers can explore more about the role of bFGF in stem cell cultures at NCBI and FDA’s Biologics. - Tissue Engineering:
In tissue engineering, bFGF plays a key role in promoting tissue repair and regeneration. Its angiogenic properties enhance vascularization in engineered tissues, improving their viability for therapeutic purposes. For more on tissue engineering, visit the National Center for Biotechnology Information (NCBI) and FDA. - Wound Healing and Angiogenesis:
GMP bFGF is used to promote wound healing by stimulating the growth of blood vessels and fibroblasts, which are essential for tissue repair. The angiogenic properties of bFGF make it a promising candidate in treatments aimed at enhancing wound recovery. More about the role of bFGF in wound healing can be found at the National Institute of General Medical Sciences (NIGMS) and Centers for Disease Control and Prevention (CDC). - Drug Development and Cancer Research:
bFGF is involved in cancer progression and tumor angiogenesis, making it an important target in cancer research. GMP bFGF protein is often used in studies focusing on the inhibition of angiogenesis in tumors. Learn more about the role of bFGF in cancer research at National Cancer Institute (NCI) and NIH.
GMP Production and Benefits
Good Manufacturing Practice (GMP) refers to a system of standards ensuring that products are consistently produced and controlled according to quality guidelines. GMP-grade bFGF protein is manufactured in a highly controlled environment, ensuring its suitability for clinical applications. The stringent production protocols minimize contamination risks, making GMP bFGF ideal for therapeutic uses, including stem cell therapies.
The importance of GMP in biological manufacturing is outlined by regulatory bodies such as the Food and Drug Administration (FDA) and European Medicines Agency (EMA). These guidelines ensure that recombinant proteins like bFGF are safe for use in humans and meet strict purity and activity standards.
Stability and Storage
GMP recombinant human bFGF protein is highly stable when stored under appropriate conditions. For long-term storage, it is recommended to store the protein at -20°C to -80°C, avoiding repeated freeze-thaw cycles. More on protein stability and storage practices can be found at NIH’s Biotech Resources.
Conclusion
The GMP recombinant human bFGF protein is indispensable in fields such as regenerative medicine, stem cell research, and tissue engineering. Its high purity, safety, and functional consistency make it a key reagent in both research and therapeutic applications. For researchers and clinicians working on cutting-edge therapies, GMP bFGF provides a reliable and safe growth factor essential for advancing cell-based treatments and regenerative solutions.
Further reading on GMP protein production and its applications in clinical research can be found at FDA’s Cell and Gene Therapy Guidelines and the National Center for Advancing Translational Sciences (NCATS).
References and Resources
Here are some educational and government resources related to GMP bFGF protein:
- National Institutes of Health (NIH)
- Food and Drug Administration (FDA)
- National Cancer Institute (NCI)
- National Institute of General Medical Sciences (NIGMS)
- Centers for Disease Control and Prevention (CDC)
- National Center for Advancing Translational Sciences (NCATS)
- European Medicines Agency (EMA)
- PubMed
- NCBI
- NIH’s Genome Research
- National Human Genome Research Institute (NHGRI)
- National Library of Medicine (NLM)
- U.S. Department of Health and Human Services (HHS


